APLN and myalgic encephalomeyelitis/chronic fatigue syndrome: These findings indicated that apelin-13 showed protective effects in CFs on attenuating fibrosis via inhibiting PI3K/Akt pathway; while apelin-13 had adverse effects in cardiomyocytes on promoting hypertrophy via enhancing PI3K/Akt signaling.